- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Index Pharmaceuticals Holding AB
Headquarters: Stockholm, Sweden
Website: N/A
Year Founded: 2000
Status: Reverse-merged
BioCentury | Feb 28, 2024
Product Development
Clinical report: Early efficacy signals triple Janux’s value; Tarsus reveals tick-killing data
Plus: readouts from Sanofi in hives, GSK in gonorrhea; Shionogi’s digital therapeutic and InDex’s next steps
BioCentury | Nov 22, 2023
Deals
Nov. 22 Quick Takes: Boehringer buying bacterial oncology play T3
Plus: Syncona reaches deal to take Freeline private, and updates from InDex, Evelo and more
BioCentury | Oct 3, 2023
Management Tracks
Affibody names Peter Zerhouni CFO
Plus: Restructuring at Kezar as CEO, CMO step down, and updates from Atomwise, Aura, Twist, Acelyrin and more
BioCentury | Jun 1, 2022
Data Byte
S1PR1 and IL-23 inhibitor pipeline for ulcerative colitis
At least nine candidates in clinical testing behind marketed therapies Zeposia and Stelara
BioCentury | Mar 6, 2021
Product Development
The pace of new modality approvals is picking up
Close to 30 new modality drugs approved in the last five years, and about 50 in registrational trials
BioCentury | Aug 28, 2019
Clinical News
Aug. 28 Clinical Quick Takes: InDex's cobitolimod hits Phase IIb endpoint in UC; plus AstraZeneca and Mitsubishi
BioCentury | Apr 22, 2017
Finance
Sweden heating up
How private money and retail investors are fueling Stockholm’s biotech IPO boom
Items per page:
1 - 10 of 13